Project
Inflammatory response time course, HUVEC (Wada et al., 2009)
Navigation
Downloads
Results for BATF
Z-value: 1.66
Motif logo
Transcription factors associated with BATF
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
BATF
|
ENSG00000156127.6 | basic leucine zipper ATF-like transcription factor |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| BATF | hg19_v2_chr14_+_75988768_75988826 | -0.20 | 3.4e-01 | Click! |
Activity profile of BATF motif
Sorted Z-values of BATF motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr1_-_153521597 | 10.72 |
ENST00000368712.1
|
S100A3
|
S100 calcium binding protein A3 |
| chr1_-_153521714 | 9.65 |
ENST00000368713.3
|
S100A3
|
S100 calcium binding protein A3 |
| chr3_-_127455200 | 9.08 |
ENST00000398101.3
|
MGLL
|
monoglyceride lipase |
| chr15_+_89182156 | 8.31 |
ENST00000379224.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
| chr15_+_67458357 | 7.70 |
ENST00000537194.2
|
SMAD3
|
SMAD family member 3 |
| chr15_+_89181974 | 7.45 |
ENST00000306072.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
| chr11_-_102668879 | 7.26 |
ENST00000315274.6
|
MMP1
|
matrix metallopeptidase 1 (interstitial collagenase) |
| chr15_-_80263506 | 7.15 |
ENST00000335661.6
|
BCL2A1
|
BCL2-related protein A1 |
| chr10_+_91087651 | 7.05 |
ENST00000371818.4
|
IFIT3
|
interferon-induced protein with tetratricopeptide repeats 3 |
| chr2_+_152214098 | 6.96 |
ENST00000243347.3
|
TNFAIP6
|
tumor necrosis factor, alpha-induced protein 6 |
| chr1_+_101185290 | 6.84 |
ENST00000370119.4
ENST00000347652.2 ENST00000294728.2 ENST00000370115.1 |
VCAM1
|
vascular cell adhesion molecule 1 |
| chr7_-_92777606 | 6.82 |
ENST00000437805.1
ENST00000446959.1 ENST00000439952.1 ENST00000414791.1 ENST00000446033.1 ENST00000411955.1 ENST00000318238.4 |
SAMD9L
|
sterile alpha motif domain containing 9-like |
| chr15_+_67418047 | 6.73 |
ENST00000540846.2
|
SMAD3
|
SMAD family member 3 |
| chr4_+_74606223 | 6.51 |
ENST00000307407.3
ENST00000401931.1 |
IL8
|
interleukin 8 |
| chr4_-_76944621 | 6.41 |
ENST00000306602.1
|
CXCL10
|
chemokine (C-X-C motif) ligand 10 |
| chr15_+_89182178 | 6.39 |
ENST00000559876.1
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
| chr19_+_4229495 | 6.39 |
ENST00000221847.5
|
EBI3
|
Epstein-Barr virus induced 3 |
| chr21_+_26934165 | 6.03 |
ENST00000456917.1
|
MIR155HG
|
MIR155 host gene (non-protein coding) |
| chr5_+_35856951 | 5.76 |
ENST00000303115.3
ENST00000343305.4 ENST00000506850.1 ENST00000511982.1 |
IL7R
|
interleukin 7 receptor |
| chr2_-_225811747 | 5.59 |
ENST00000409592.3
|
DOCK10
|
dedicator of cytokinesis 10 |
| chr10_-_6019984 | 5.42 |
ENST00000525219.2
|
IL15RA
|
interleukin 15 receptor, alpha |
| chr1_-_8000872 | 5.41 |
ENST00000377507.3
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9 |
| chr10_-_49860525 | 5.27 |
ENST00000435790.2
|
ARHGAP22
|
Rho GTPase activating protein 22 |
| chr11_+_102188272 | 5.06 |
ENST00000532808.1
|
BIRC3
|
baculoviral IAP repeat containing 3 |
| chr7_+_55177416 | 4.81 |
ENST00000450046.1
ENST00000454757.2 |
EGFR
|
epidermal growth factor receptor |
| chr3_-_157251383 | 4.60 |
ENST00000487753.1
ENST00000489602.1 ENST00000461299.1 ENST00000479987.1 |
VEPH1
|
ventricular zone expressed PH domain-containing 1 |
| chr21_+_42798094 | 4.38 |
ENST00000398598.3
ENST00000455164.2 ENST00000424365.1 |
MX1
|
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
| chr3_+_11178779 | 4.37 |
ENST00000438284.2
|
HRH1
|
histamine receptor H1 |
| chr17_-_34207295 | 4.34 |
ENST00000463941.1
ENST00000293272.3 |
CCL5
|
chemokine (C-C motif) ligand 5 |
| chr1_-_209824643 | 4.20 |
ENST00000391911.1
ENST00000415782.1 |
LAMB3
|
laminin, beta 3 |
| chr12_+_56075330 | 4.01 |
ENST00000394252.3
|
METTL7B
|
methyltransferase like 7B |
| chr2_+_161993465 | 3.99 |
ENST00000457476.1
|
TANK
|
TRAF family member-associated NFKB activator |
| chr14_-_91710852 | 3.91 |
ENST00000535815.1
ENST00000529102.1 |
GPR68
|
G protein-coupled receptor 68 |
| chr21_+_43619796 | 3.88 |
ENST00000398457.2
|
ABCG1
|
ATP-binding cassette, sub-family G (WHITE), member 1 |
| chr6_+_127898312 | 3.87 |
ENST00000329722.7
|
C6orf58
|
chromosome 6 open reading frame 58 |
| chr10_+_91092241 | 3.78 |
ENST00000371811.4
|
IFIT3
|
interferon-induced protein with tetratricopeptide repeats 3 |
| chr3_+_105085734 | 3.71 |
ENST00000306107.5
|
ALCAM
|
activated leukocyte cell adhesion molecule |
| chr10_-_6019552 | 3.69 |
ENST00000379977.3
ENST00000397251.3 ENST00000397248.2 |
IL15RA
|
interleukin 15 receptor, alpha |
| chr20_-_44176013 | 3.67 |
ENST00000555685.1
|
EPPIN
|
epididymal peptidase inhibitor |
| chr1_+_169079823 | 3.57 |
ENST00000367813.3
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
| chr19_-_44174330 | 3.54 |
ENST00000340093.3
|
PLAUR
|
plasminogen activator, urokinase receptor |
| chr6_-_137539651 | 3.46 |
ENST00000543628.1
|
IFNGR1
|
interferon gamma receptor 1 |
| chr5_-_150460914 | 3.41 |
ENST00000389378.2
|
TNIP1
|
TNFAIP3 interacting protein 1 |
| chr1_-_205290865 | 3.40 |
ENST00000367157.3
|
NUAK2
|
NUAK family, SNF1-like kinase, 2 |
| chr11_-_65430251 | 3.36 |
ENST00000534283.1
ENST00000527749.1 ENST00000533187.1 ENST00000525693.1 ENST00000534558.1 ENST00000532879.1 ENST00000532999.1 |
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A |
| chr2_+_201981527 | 3.35 |
ENST00000441224.1
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
| chr16_-_11680759 | 3.33 |
ENST00000571459.1
ENST00000570798.1 ENST00000572255.1 ENST00000574763.1 ENST00000574703.1 ENST00000571277.1 ENST00000381810.3 |
LITAF
|
lipopolysaccharide-induced TNF factor |
| chr10_-_49812997 | 3.28 |
ENST00000417912.2
|
ARHGAP22
|
Rho GTPase activating protein 22 |
| chr1_-_89531041 | 3.21 |
ENST00000370473.4
|
GBP1
|
guanylate binding protein 1, interferon-inducible |
| chr16_+_57662138 | 3.16 |
ENST00000562414.1
ENST00000561969.1 ENST00000562631.1 ENST00000563445.1 ENST00000565338.1 ENST00000567702.1 |
GPR56
|
G protein-coupled receptor 56 |
| chr16_+_57662419 | 3.12 |
ENST00000388812.4
ENST00000538815.1 ENST00000456916.1 ENST00000567154.1 ENST00000388813.5 ENST00000562558.1 ENST00000566271.2 |
GPR56
|
G protein-coupled receptor 56 |
| chr15_+_71145578 | 3.12 |
ENST00000544974.2
ENST00000558546.1 |
LRRC49
|
leucine rich repeat containing 49 |
| chr1_+_183155373 | 3.07 |
ENST00000493293.1
ENST00000264144.4 |
LAMC2
|
laminin, gamma 2 |
| chr2_+_102721023 | 3.06 |
ENST00000409589.1
ENST00000409329.1 |
IL1R1
|
interleukin 1 receptor, type I |
| chr16_+_57023406 | 3.03 |
ENST00000262510.6
ENST00000308149.7 ENST00000436936.1 |
NLRC5
|
NLR family, CARD domain containing 5 |
| chr6_-_138428613 | 2.92 |
ENST00000421351.3
|
PERP
|
PERP, TP53 apoptosis effector |
| chr11_+_102188224 | 2.85 |
ENST00000263464.3
|
BIRC3
|
baculoviral IAP repeat containing 3 |
| chr2_+_161993412 | 2.79 |
ENST00000259075.2
ENST00000432002.1 |
TANK
|
TRAF family member-associated NFKB activator |
| chr5_+_118690466 | 2.67 |
ENST00000503646.1
|
TNFAIP8
|
tumor necrosis factor, alpha-induced protein 8 |
| chr17_+_21191341 | 2.67 |
ENST00000526076.2
ENST00000361818.5 ENST00000316920.6 |
MAP2K3
|
mitogen-activated protein kinase kinase 3 |
| chr11_-_57177586 | 2.62 |
ENST00000529411.1
|
RP11-872D17.8
|
Uncharacterized protein |
| chr16_+_66442411 | 2.61 |
ENST00000499966.1
|
LINC00920
|
long intergenic non-protein coding RNA 920 |
| chr10_-_49813090 | 2.60 |
ENST00000249601.4
|
ARHGAP22
|
Rho GTPase activating protein 22 |
| chr17_+_74381343 | 2.56 |
ENST00000392496.3
|
SPHK1
|
sphingosine kinase 1 |
| chr10_+_104155450 | 2.55 |
ENST00000471698.1
ENST00000189444.6 |
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
| chr12_+_75874580 | 2.55 |
ENST00000456650.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
| chr3_+_148447887 | 2.55 |
ENST00000475347.1
ENST00000474935.1 ENST00000461609.1 |
AGTR1
|
angiotensin II receptor, type 1 |
| chr4_-_122085469 | 2.50 |
ENST00000057513.3
|
TNIP3
|
TNFAIP3 interacting protein 3 |
| chr16_+_56642489 | 2.46 |
ENST00000561491.1
|
MT2A
|
metallothionein 2A |
| chr3_+_10206545 | 2.45 |
ENST00000256458.4
|
IRAK2
|
interleukin-1 receptor-associated kinase 2 |
| chr2_+_201997595 | 2.44 |
ENST00000470178.2
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
| chr16_+_56642041 | 2.38 |
ENST00000245185.5
|
MT2A
|
metallothionein 2A |
| chr2_+_201997492 | 2.35 |
ENST00000494258.1
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
| chr16_+_56685796 | 2.34 |
ENST00000334346.2
ENST00000562399.1 |
MT1B
|
metallothionein 1B |
| chr3_+_105086056 | 2.34 |
ENST00000472644.2
|
ALCAM
|
activated leukocyte cell adhesion molecule |
| chr19_-_44174305 | 2.26 |
ENST00000601723.1
ENST00000339082.3 |
PLAUR
|
plasminogen activator, urokinase receptor |
| chr2_-_113542063 | 2.23 |
ENST00000263339.3
|
IL1A
|
interleukin 1, alpha |
| chr5_-_61031495 | 2.21 |
ENST00000506550.1
ENST00000512882.2 |
CTD-2170G1.2
|
CTD-2170G1.2 |
| chr22_+_41697520 | 2.18 |
ENST00000352645.4
|
ZC3H7B
|
zinc finger CCCH-type containing 7B |
| chr10_-_6019455 | 2.17 |
ENST00000530685.1
ENST00000397255.3 ENST00000379971.1 ENST00000528354.1 ENST00000397250.2 ENST00000429135.2 |
IL15RA
|
interleukin 15 receptor, alpha |
| chr5_-_16916624 | 2.07 |
ENST00000513882.1
|
MYO10
|
myosin X |
| chr6_-_44233361 | 2.07 |
ENST00000275015.5
|
NFKBIE
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon |
| chr4_+_8321882 | 2.06 |
ENST00000509453.1
ENST00000503186.1 |
RP11-774O3.2
RP11-774O3.1
|
RP11-774O3.2 RP11-774O3.1 |
| chr11_+_122526383 | 2.06 |
ENST00000284273.5
|
UBASH3B
|
ubiquitin associated and SH3 domain containing B |
| chr3_+_30648066 | 2.06 |
ENST00000359013.4
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa) |
| chr17_-_28257080 | 2.06 |
ENST00000579954.1
ENST00000540801.1 ENST00000269033.3 ENST00000590153.1 ENST00000582084.1 |
SSH2
|
slingshot protein phosphatase 2 |
| chr12_-_57522813 | 2.06 |
ENST00000556155.1
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced |
| chr6_-_11779840 | 2.05 |
ENST00000506810.1
|
ADTRP
|
androgen-dependent TFPI-regulating protein |
| chr16_-_84538218 | 2.04 |
ENST00000562447.1
ENST00000565765.1 ENST00000535580.1 ENST00000343629.6 |
TLDC1
|
TBC/LysM-associated domain containing 1 |
| chr9_+_109694914 | 2.02 |
ENST00000542028.1
|
ZNF462
|
zinc finger protein 462 |
| chr3_+_133293278 | 2.01 |
ENST00000508481.1
ENST00000420115.2 ENST00000504867.1 ENST00000507408.1 ENST00000511392.1 ENST00000515421.1 |
CDV3
|
CDV3 homolog (mouse) |
| chr3_+_151531810 | 2.00 |
ENST00000232892.7
|
AADAC
|
arylacetamide deacetylase |
| chr3_-_195997410 | 2.00 |
ENST00000419333.1
|
PCYT1A
|
phosphate cytidylyltransferase 1, choline, alpha |
| chr3_-_123411191 | 2.00 |
ENST00000354792.5
ENST00000508240.1 |
MYLK
|
myosin light chain kinase |
| chr15_-_55563072 | 2.00 |
ENST00000567380.1
ENST00000565972.1 ENST00000569493.1 |
RAB27A
|
RAB27A, member RAS oncogene family |
| chr10_+_60028818 | 1.99 |
ENST00000333926.5
|
CISD1
|
CDGSH iron sulfur domain 1 |
| chr7_-_22234381 | 1.98 |
ENST00000458533.1
|
RAPGEF5
|
Rap guanine nucleotide exchange factor (GEF) 5 |
| chr15_+_28624878 | 1.93 |
ENST00000450328.2
|
GOLGA8F
|
golgin A8 family, member F |
| chr12_+_121570631 | 1.93 |
ENST00000546057.1
ENST00000377162.2 ENST00000328963.5 ENST00000535250.1 ENST00000541446.1 |
P2RX7
|
purinergic receptor P2X, ligand-gated ion channel, 7 |
| chr1_-_6662919 | 1.90 |
ENST00000377658.4
ENST00000377663.3 |
KLHL21
|
kelch-like family member 21 |
| chr5_-_150473127 | 1.90 |
ENST00000521001.1
|
TNIP1
|
TNFAIP3 interacting protein 1 |
| chr2_+_102953608 | 1.88 |
ENST00000311734.2
ENST00000409584.1 |
IL1RL1
|
interleukin 1 receptor-like 1 |
| chr21_-_36421535 | 1.84 |
ENST00000416754.1
ENST00000437180.1 ENST00000455571.1 |
RUNX1
|
runt-related transcription factor 1 |
| chr4_+_15704573 | 1.84 |
ENST00000265016.4
|
BST1
|
bone marrow stromal cell antigen 1 |
| chr11_-_2950642 | 1.82 |
ENST00000314222.4
|
PHLDA2
|
pleckstrin homology-like domain, family A, member 2 |
| chr17_+_79650962 | 1.80 |
ENST00000329138.4
|
HGS
|
hepatocyte growth factor-regulated tyrosine kinase substrate |
| chr1_+_15671580 | 1.79 |
ENST00000529606.1
ENST00000314740.8 |
FHAD1
|
forkhead-associated (FHA) phosphopeptide binding domain 1 |
| chr18_+_61637159 | 1.79 |
ENST00000397985.2
ENST00000353706.2 ENST00000542677.1 ENST00000397988.3 ENST00000448851.1 |
SERPINB8
|
serpin peptidase inhibitor, clade B (ovalbumin), member 8 |
| chr3_+_30647994 | 1.78 |
ENST00000295754.5
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa) |
| chr21_-_36421626 | 1.78 |
ENST00000300305.3
|
RUNX1
|
runt-related transcription factor 1 |
| chr11_+_61957687 | 1.77 |
ENST00000306238.3
|
SCGB1D1
|
secretoglobin, family 1D, member 1 |
| chrX_-_154563889 | 1.77 |
ENST00000369449.2
ENST00000321926.4 |
CLIC2
|
chloride intracellular channel 2 |
| chr6_+_29068386 | 1.74 |
ENST00000377171.3
|
OR2J1
|
olfactory receptor, family 2, subfamily J, member 1 (gene/pseudogene) |
| chr4_+_139936905 | 1.73 |
ENST00000280614.2
|
CCRN4L
|
CCR4 carbon catabolite repression 4-like (S. cerevisiae) |
| chr15_-_40213080 | 1.72 |
ENST00000561100.1
|
GPR176
|
G protein-coupled receptor 176 |
| chr3_+_46448648 | 1.72 |
ENST00000399036.3
|
CCRL2
|
chemokine (C-C motif) receptor-like 2 |
| chr2_-_204400113 | 1.71 |
ENST00000319170.5
|
RAPH1
|
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 |
| chr22_-_21386838 | 1.71 |
ENST00000403586.1
ENST00000382932.2 |
SLC7A4
|
solute carrier family 7, member 4 |
| chr3_-_194188956 | 1.70 |
ENST00000256031.4
ENST00000446356.1 |
ATP13A3
|
ATPase type 13A3 |
| chr18_+_21718924 | 1.70 |
ENST00000399496.3
|
CABYR
|
calcium binding tyrosine-(Y)-phosphorylation regulated |
| chr5_+_125695805 | 1.70 |
ENST00000513040.1
|
GRAMD3
|
GRAM domain containing 3 |
| chr18_-_33702078 | 1.69 |
ENST00000586829.1
|
SLC39A6
|
solute carrier family 39 (zinc transporter), member 6 |
| chr12_+_113376157 | 1.69 |
ENST00000228928.7
|
OAS3
|
2'-5'-oligoadenylate synthetase 3, 100kDa |
| chr11_-_65430554 | 1.68 |
ENST00000308639.9
ENST00000406246.3 |
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A |
| chr11_+_60197069 | 1.68 |
ENST00000528905.1
ENST00000528093.1 |
MS4A5
|
membrane-spanning 4-domains, subfamily A, member 5 |
| chr3_-_47823298 | 1.68 |
ENST00000254480.5
|
SMARCC1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 |
| chr8_+_145149930 | 1.67 |
ENST00000318911.4
|
CYC1
|
cytochrome c-1 |
| chr6_-_11382478 | 1.66 |
ENST00000397378.3
ENST00000513989.1 ENST00000508546.1 ENST00000504387.1 |
NEDD9
|
neural precursor cell expressed, developmentally down-regulated 9 |
| chr16_-_67970990 | 1.66 |
ENST00000358514.4
|
PSMB10
|
proteasome (prosome, macropain) subunit, beta type, 10 |
| chr15_-_71146480 | 1.65 |
ENST00000299213.8
|
LARP6
|
La ribonucleoprotein domain family, member 6 |
| chr9_+_103189405 | 1.63 |
ENST00000395067.2
|
MSANTD3
|
Myb/SANT-like DNA-binding domain containing 3 |
| chr2_+_168043793 | 1.63 |
ENST00000409273.1
ENST00000409605.1 |
XIRP2
|
xin actin-binding repeat containing 2 |
| chr1_+_110453109 | 1.63 |
ENST00000525659.1
|
CSF1
|
colony stimulating factor 1 (macrophage) |
| chr17_+_33570055 | 1.63 |
ENST00000299977.4
ENST00000542451.1 ENST00000592325.1 |
SLFN5
|
schlafen family member 5 |
| chr5_+_54320078 | 1.62 |
ENST00000231009.2
|
GZMK
|
granzyme K (granzyme 3; tryptase II) |
| chr12_+_113354341 | 1.60 |
ENST00000553152.1
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
| chr16_-_80603558 | 1.60 |
ENST00000567317.1
|
RP11-18F14.1
|
RP11-18F14.1 |
| chr6_-_46293378 | 1.59 |
ENST00000330430.6
|
RCAN2
|
regulator of calcineurin 2 |
| chr2_+_108994633 | 1.58 |
ENST00000409309.3
|
SULT1C4
|
sulfotransferase family, cytosolic, 1C, member 4 |
| chr2_-_231989808 | 1.57 |
ENST00000258400.3
|
HTR2B
|
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled |
| chr16_+_8891670 | 1.56 |
ENST00000268261.4
ENST00000539622.1 ENST00000569958.1 ENST00000537352.1 |
PMM2
|
phosphomannomutase 2 |
| chr1_+_156084461 | 1.54 |
ENST00000347559.2
ENST00000361308.4 ENST00000368300.4 ENST00000368299.3 |
LMNA
|
lamin A/C |
| chr6_-_32784687 | 1.54 |
ENST00000447394.1
ENST00000438763.2 |
HLA-DOB
|
major histocompatibility complex, class II, DO beta |
| chr14_+_55221541 | 1.54 |
ENST00000555192.1
|
SAMD4A
|
sterile alpha motif domain containing 4A |
| chr17_-_41623259 | 1.54 |
ENST00000538265.1
ENST00000591713.1 |
ETV4
|
ets variant 4 |
| chr5_-_13944652 | 1.54 |
ENST00000265104.4
|
DNAH5
|
dynein, axonemal, heavy chain 5 |
| chr19_-_54872556 | 1.52 |
ENST00000444687.1
|
LAIR1
|
leukocyte-associated immunoglobulin-like receptor 1 |
| chr21_-_35899113 | 1.52 |
ENST00000492600.1
ENST00000481448.1 ENST00000381132.2 |
RCAN1
|
regulator of calcineurin 1 |
| chr11_-_18610246 | 1.50 |
ENST00000379387.4
ENST00000541984.1 |
UEVLD
|
UEV and lactate/malate dehyrogenase domains |
| chr14_+_52164820 | 1.50 |
ENST00000554167.1
|
FRMD6
|
FERM domain containing 6 |
| chr7_+_134528635 | 1.50 |
ENST00000445569.2
|
CALD1
|
caldesmon 1 |
| chr16_-_12184159 | 1.49 |
ENST00000312019.2
|
RP11-276H1.3
|
RP11-276H1.3 |
| chr17_+_32582293 | 1.49 |
ENST00000580907.1
ENST00000225831.4 |
CCL2
|
chemokine (C-C motif) ligand 2 |
| chr12_+_75874460 | 1.48 |
ENST00000266659.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
| chr10_+_91061712 | 1.48 |
ENST00000371826.3
|
IFIT2
|
interferon-induced protein with tetratricopeptide repeats 2 |
| chr4_+_70916119 | 1.47 |
ENST00000246896.3
ENST00000511674.1 |
HTN1
|
histatin 1 |
| chr6_+_159084188 | 1.47 |
ENST00000367081.3
|
SYTL3
|
synaptotagmin-like 3 |
| chr7_+_129932974 | 1.47 |
ENST00000445470.2
ENST00000222482.4 ENST00000492072.1 ENST00000473956.1 ENST00000493259.1 ENST00000486598.1 |
CPA4
|
carboxypeptidase A4 |
| chr3_+_63953415 | 1.46 |
ENST00000484332.1
|
ATXN7
|
ataxin 7 |
| chr1_+_155107820 | 1.45 |
ENST00000484157.1
|
SLC50A1
|
solute carrier family 50 (sugar efflux transporter), member 1 |
| chr19_+_45254529 | 1.45 |
ENST00000444487.1
|
BCL3
|
B-cell CLL/lymphoma 3 |
| chr12_+_108908962 | 1.43 |
ENST00000552695.1
ENST00000552758.1 ENST00000361549.2 |
FICD
|
FIC domain containing |
| chr6_-_35888905 | 1.43 |
ENST00000510290.1
ENST00000423325.2 ENST00000373822.1 |
SRPK1
|
SRSF protein kinase 1 |
| chr5_+_179247759 | 1.42 |
ENST00000389805.4
ENST00000504627.1 ENST00000402874.3 ENST00000510187.1 |
SQSTM1
|
sequestosome 1 |
| chr11_-_65667997 | 1.41 |
ENST00000312562.2
ENST00000534222.1 |
FOSL1
|
FOS-like antigen 1 |
| chr1_+_233765353 | 1.40 |
ENST00000366620.1
|
KCNK1
|
potassium channel, subfamily K, member 1 |
| chr22_+_23487513 | 1.40 |
ENST00000263116.2
ENST00000341989.4 |
RAB36
|
RAB36, member RAS oncogene family |
| chr11_-_65667884 | 1.40 |
ENST00000448083.2
ENST00000531493.1 ENST00000532401.1 |
FOSL1
|
FOS-like antigen 1 |
| chr11_-_51412448 | 1.38 |
ENST00000319760.6
|
OR4A5
|
olfactory receptor, family 4, subfamily A, member 5 |
| chr4_-_80994619 | 1.38 |
ENST00000404191.1
|
ANTXR2
|
anthrax toxin receptor 2 |
| chr1_+_87012753 | 1.38 |
ENST00000370563.3
|
CLCA4
|
chloride channel accessory 4 |
| chr2_+_103035102 | 1.37 |
ENST00000264260.2
|
IL18RAP
|
interleukin 18 receptor accessory protein |
| chr11_+_19799327 | 1.36 |
ENST00000540292.1
|
NAV2
|
neuron navigator 2 |
| chr15_-_72523924 | 1.36 |
ENST00000566809.1
ENST00000567087.1 ENST00000569050.1 ENST00000568883.1 |
PKM
|
pyruvate kinase, muscle |
| chr2_+_201997676 | 1.35 |
ENST00000462763.1
ENST00000479953.2 |
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
| chr2_-_152146385 | 1.32 |
ENST00000414946.1
ENST00000243346.5 |
NMI
|
N-myc (and STAT) interactor |
| chr3_-_157221357 | 1.32 |
ENST00000494677.1
|
VEPH1
|
ventricular zone expressed PH domain-containing 1 |
| chr7_+_128095900 | 1.32 |
ENST00000435296.2
|
HILPDA
|
hypoxia inducible lipid droplet-associated |
| chr11_+_63974135 | 1.31 |
ENST00000544997.1
ENST00000345728.5 ENST00000279227.5 |
FERMT3
|
fermitin family member 3 |
| chr3_+_127770455 | 1.31 |
ENST00000464451.1
|
SEC61A1
|
Sec61 alpha 1 subunit (S. cerevisiae) |
| chr11_+_5710919 | 1.30 |
ENST00000379965.3
ENST00000425490.1 |
TRIM22
|
tripartite motif containing 22 |
| chr22_-_43090992 | 1.30 |
ENST00000401850.1
|
A4GALT
|
alpha 1,4-galactosyltransferase |
| chr10_+_24755416 | 1.29 |
ENST00000396446.1
ENST00000396445.1 ENST00000376451.2 |
KIAA1217
|
KIAA1217 |
| chr20_-_45061695 | 1.29 |
ENST00000445496.2
|
ELMO2
|
engulfment and cell motility 2 |
| chr18_+_21719018 | 1.28 |
ENST00000585037.1
ENST00000415309.2 ENST00000399481.2 ENST00000577705.1 ENST00000327201.6 |
CABYR
|
calcium binding tyrosine-(Y)-phosphorylation regulated |
| chr6_-_84140757 | 1.27 |
ENST00000541327.1
ENST00000369705.3 ENST00000543031.1 |
ME1
|
malic enzyme 1, NADP(+)-dependent, cytosolic |
| chr3_-_157221380 | 1.27 |
ENST00000468233.1
|
VEPH1
|
ventricular zone expressed PH domain-containing 1 |
| chr6_+_151042224 | 1.27 |
ENST00000358517.2
|
PLEKHG1
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 1 |
| chr19_+_6531010 | 1.25 |
ENST00000245817.3
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9 |
| chr20_+_43160458 | 1.25 |
ENST00000372889.1
ENST00000372887.1 ENST00000372882.3 |
PKIG
|
protein kinase (cAMP-dependent, catalytic) inhibitor gamma |
| chr7_-_143105941 | 1.24 |
ENST00000275815.3
|
EPHA1
|
EPH receptor A1 |
| chr7_-_1498962 | 1.24 |
ENST00000405088.4
|
MICALL2
|
MICAL-like 2 |
| chr1_+_167691191 | 1.24 |
ENST00000392121.3
ENST00000474859.1 |
MPZL1
|
myelin protein zero-like 1 |
| chr17_-_39296739 | 1.23 |
ENST00000345847.4
|
KRTAP4-6
|
keratin associated protein 4-6 |
| chr3_-_11762202 | 1.23 |
ENST00000445411.1
ENST00000404339.1 ENST00000273038.3 |
VGLL4
|
vestigial like 4 (Drosophila) |
| chr18_+_21693306 | 1.22 |
ENST00000540918.2
|
TTC39C
|
tetratricopeptide repeat domain 39C |
| chr2_+_106468204 | 1.22 |
ENST00000425756.1
ENST00000393349.2 |
NCK2
|
NCK adaptor protein 2 |
| chr14_-_81893734 | 1.22 |
ENST00000555447.1
|
STON2
|
stonin 2 |
| chr5_-_156486120 | 1.22 |
ENST00000522693.1
|
HAVCR1
|
hepatitis A virus cellular receptor 1 |
| chr9_-_136203235 | 1.21 |
ENST00000372022.4
|
SURF6
|
surfeit 6 |
Network of associatons between targets according to the STRING database.
First level regulatory network of BATF
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.4 | 22.1 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 2.9 | 14.4 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
| 1.6 | 17.5 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
| 1.4 | 5.8 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 1.4 | 9.9 | GO:0033590 | response to cobalamin(GO:0033590) |
| 1.3 | 5.3 | GO:0052250 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 1.3 | 3.8 | GO:0002661 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
| 1.1 | 8.0 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 1.1 | 6.8 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 1.1 | 4.3 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 1.1 | 3.2 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
| 1.0 | 3.1 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 1.0 | 4.0 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
| 1.0 | 3.9 | GO:0055099 | detection of endogenous stimulus(GO:0009726) response to high density lipoprotein particle(GO:0055099) |
| 1.0 | 4.8 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.9 | 12.3 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
| 0.9 | 6.2 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.9 | 4.3 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.9 | 2.6 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 0.8 | 3.2 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.8 | 2.3 | GO:0039019 | pronephric nephron development(GO:0039019) |
| 0.7 | 2.2 | GO:2000391 | positive regulation of neutrophil extravasation(GO:2000391) |
| 0.7 | 0.7 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
| 0.7 | 5.6 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.7 | 4.2 | GO:2001183 | negative regulation of interleukin-10 secretion(GO:2001180) negative regulation of interleukin-12 secretion(GO:2001183) |
| 0.7 | 8.1 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
| 0.7 | 1.3 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
| 0.7 | 2.6 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.6 | 1.9 | GO:0060381 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.6 | 4.3 | GO:1901318 | negative regulation of sperm motility(GO:1901318) |
| 0.6 | 1.8 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.6 | 2.3 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.6 | 4.6 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.6 | 6.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.5 | 2.7 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.5 | 6.5 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.5 | 3.2 | GO:0003383 | apical constriction(GO:0003383) |
| 0.5 | 2.1 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 0.5 | 1.5 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 0.5 | 1.5 | GO:0071301 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
| 0.5 | 1.5 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
| 0.5 | 3.9 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.5 | 1.0 | GO:0001545 | primary ovarian follicle growth(GO:0001545) |
| 0.5 | 2.8 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.5 | 1.4 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.5 | 1.4 | GO:1901656 | glycoside transport(GO:1901656) |
| 0.5 | 1.4 | GO:0070541 | response to platinum ion(GO:0070541) |
| 0.5 | 2.7 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 0.4 | 1.8 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
| 0.4 | 4.3 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 0.4 | 4.4 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 0.4 | 1.6 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.4 | 0.4 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.4 | 1.1 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
| 0.4 | 1.4 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.3 | 4.0 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.3 | 2.7 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.3 | 2.0 | GO:0043316 | cytotoxic T cell degranulation(GO:0043316) positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.3 | 1.6 | GO:1904141 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 0.3 | 1.6 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.3 | 1.3 | GO:0006218 | uridine catabolic process(GO:0006218) |
| 0.3 | 1.9 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.3 | 1.6 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
| 0.3 | 1.2 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.3 | 2.8 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 0.3 | 8.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.3 | 0.9 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 0.3 | 4.7 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.3 | 2.0 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.3 | 1.1 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.3 | 0.8 | GO:0046210 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) |
| 0.3 | 1.4 | GO:0021564 | vagus nerve development(GO:0021564) |
| 0.3 | 0.8 | GO:2000863 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
| 0.3 | 3.9 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
| 0.3 | 0.8 | GO:0048627 | myoblast development(GO:0048627) |
| 0.3 | 1.0 | GO:0072255 | metanephric mesangial cell differentiation(GO:0072209) metanephric glomerular mesangial cell differentiation(GO:0072254) metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
| 0.2 | 1.0 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
| 0.2 | 1.0 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.2 | 1.0 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.2 | 0.5 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
| 0.2 | 1.0 | GO:0033625 | positive regulation of integrin activation(GO:0033625) cellular response to progesterone stimulus(GO:0071393) |
| 0.2 | 1.0 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.2 | 0.5 | GO:0045359 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.2 | 2.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.2 | 1.4 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 0.2 | 0.5 | GO:0046102 | inosine metabolic process(GO:0046102) |
| 0.2 | 2.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.2 | 0.7 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.2 | 0.9 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.2 | 1.3 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.2 | 5.8 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.2 | 0.6 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.2 | 2.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
| 0.2 | 0.8 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
| 0.2 | 1.2 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.2 | 0.8 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.2 | 0.6 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 0.2 | 0.2 | GO:2000816 | negative regulation of mitotic sister chromatid separation(GO:2000816) |
| 0.2 | 0.6 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.2 | 1.2 | GO:1904209 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 0.2 | 0.8 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.2 | 0.4 | GO:0046136 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
| 0.2 | 0.8 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.2 | 2.5 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.2 | 0.9 | GO:0015692 | lead ion transport(GO:0015692) |
| 0.2 | 0.9 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 0.2 | 1.1 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.2 | 1.5 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.2 | 0.9 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.2 | 0.2 | GO:0071231 | cellular response to folic acid(GO:0071231) |
| 0.2 | 0.6 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.2 | 0.6 | GO:2000359 | regulation of sperm capacitation(GO:1902490) regulation of binding of sperm to zona pellucida(GO:2000359) |
| 0.2 | 2.0 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.2 | 0.5 | GO:0043366 | beta selection(GO:0043366) |
| 0.2 | 0.4 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 0.2 | 0.5 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
| 0.2 | 0.5 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
| 0.2 | 0.7 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
| 0.2 | 5.9 | GO:0048846 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
| 0.2 | 2.4 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 0.2 | 0.9 | GO:0035549 | interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) |
| 0.2 | 0.5 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.2 | 4.9 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.2 | 1.0 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.2 | 0.7 | GO:0034445 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.2 | 1.0 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
| 0.2 | 0.7 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.2 | 0.3 | GO:1901536 | negative regulation of DNA demethylation(GO:1901536) |
| 0.2 | 1.3 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
| 0.2 | 0.5 | GO:0000472 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.2 | 1.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.2 | 0.3 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
| 0.2 | 0.9 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.2 | 0.8 | GO:0021633 | optic nerve structural organization(GO:0021633) |
| 0.2 | 0.3 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.1 | 1.0 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.1 | 0.9 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.1 | 0.4 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.1 | 0.7 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
| 0.1 | 5.2 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
| 0.1 | 0.3 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.1 | 0.7 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.1 | 1.1 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.1 | 0.7 | GO:0051136 | extrathymic T cell differentiation(GO:0033078) regulation of NK T cell differentiation(GO:0051136) |
| 0.1 | 0.4 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.1 | 1.9 | GO:1903543 | positive regulation of exosomal secretion(GO:1903543) |
| 0.1 | 0.7 | GO:2000320 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 0.1 | 0.8 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
| 0.1 | 0.4 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.1 | 0.3 | GO:1902903 | regulation of fibril organization(GO:1902903) |
| 0.1 | 1.5 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.1 | 0.4 | GO:0018013 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.1 | 0.4 | GO:0033341 | regulation of collagen binding(GO:0033341) |
| 0.1 | 1.4 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 0.1 | 0.5 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.1 | 0.5 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.1 | 3.7 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.1 | 0.5 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.1 | 0.4 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.1 | 0.4 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.1 | 2.0 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.1 | 2.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.1 | 0.4 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.1 | 0.7 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 | 0.3 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
| 0.1 | 0.6 | GO:0060356 | leucine import(GO:0060356) |
| 0.1 | 1.7 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.1 | 0.8 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.1 | 1.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 | 0.3 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.1 | 0.7 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.1 | 0.3 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
| 0.1 | 0.5 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 | 0.5 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
| 0.1 | 0.3 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.1 | 0.6 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.1 | 0.4 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 0.1 | 1.5 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
| 0.1 | 2.5 | GO:0051923 | sulfation(GO:0051923) |
| 0.1 | 0.3 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
| 0.1 | 0.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.1 | 1.0 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.1 | 0.3 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.1 | 0.3 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
| 0.1 | 0.9 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 0.1 | 0.5 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
| 0.1 | 0.4 | GO:0001188 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.1 | 0.5 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
| 0.1 | 0.9 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.1 | 0.4 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
| 0.1 | 0.2 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
| 0.1 | 0.6 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.1 | 0.3 | GO:0072642 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.1 | 0.5 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.1 | 0.2 | GO:0070256 | regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 0.1 | 0.3 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.1 | 1.8 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
| 0.1 | 1.9 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.1 | 0.3 | GO:0015820 | leucine transport(GO:0015820) |
| 0.1 | 0.5 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) mitotic cytokinesis checkpoint(GO:0044878) |
| 0.1 | 1.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.1 | 0.6 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
| 0.1 | 0.6 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.1 | 0.5 | GO:0071105 | response to interleukin-11(GO:0071105) |
| 0.1 | 0.4 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.1 | 1.2 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.1 | 0.3 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
| 0.1 | 0.5 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.1 | 0.4 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 | 0.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.1 | 0.6 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 | 1.9 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.1 | 1.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.1 | 0.3 | GO:0010958 | regulation of amino acid import(GO:0010958) |
| 0.1 | 0.2 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
| 0.1 | 0.2 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
| 0.1 | 1.1 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.1 | 0.8 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.1 | 1.2 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 0.1 | 0.5 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.1 | 0.8 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.1 | 0.3 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.1 | 0.1 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.1 | 0.4 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 0.1 | 1.4 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.1 | 0.5 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 | 0.2 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.1 | 0.3 | GO:0032455 | nerve growth factor processing(GO:0032455) |
| 0.1 | 1.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.1 | 0.3 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 0.1 | 1.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
| 0.1 | 0.9 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.1 | 1.4 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.1 | 0.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.1 | 0.8 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
| 0.1 | 0.1 | GO:0019563 | glycerol catabolic process(GO:0019563) |
| 0.1 | 0.7 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.1 | 0.3 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.1 | 0.2 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.1 | 0.3 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.1 | 1.6 | GO:0006999 | nuclear pore organization(GO:0006999) |
| 0.1 | 0.6 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.1 | 0.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.1 | 0.6 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
| 0.1 | 1.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 | 0.2 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.1 | 0.5 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.1 | 0.2 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.1 | 0.6 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.1 | 0.2 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.1 | 7.1 | GO:0050728 | negative regulation of inflammatory response(GO:0050728) |
| 0.1 | 0.2 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 0.1 | 0.6 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.1 | 0.9 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.1 | 0.4 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.1 | 1.5 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.1 | 2.0 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.1 | 0.3 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
| 0.1 | 0.3 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.1 | 0.1 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
| 0.1 | 0.3 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.1 | 0.7 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
| 0.1 | 0.3 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 0.1 | 0.2 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
| 0.1 | 2.0 | GO:0034629 | cellular protein complex localization(GO:0034629) |
| 0.1 | 0.3 | GO:0060005 | vestibular reflex(GO:0060005) |
| 0.1 | 0.3 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 | 0.2 | GO:0051598 | meiotic recombination checkpoint(GO:0051598) |
| 0.1 | 0.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.1 | 0.3 | GO:0097324 | melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.1 | 0.2 | GO:0001983 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
| 0.1 | 0.4 | GO:0046618 | drug export(GO:0046618) |
| 0.1 | 0.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.1 | 1.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.1 | 0.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.1 | 0.2 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
| 0.1 | 0.4 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) |
| 0.1 | 1.2 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.1 | 0.4 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
| 0.1 | 0.9 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
| 0.1 | 0.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.1 | 0.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 0.1 | 0.2 | GO:0032571 | response to vitamin K(GO:0032571) |
| 0.1 | 0.8 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
| 0.0 | 0.8 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.0 | 0.3 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.0 | 2.1 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.0 | 0.6 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.0 | 4.4 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.0 | 6.4 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.0 | 0.1 | GO:1902868 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 0.0 | 0.2 | GO:0003095 | pressure natriuresis(GO:0003095) |
| 0.0 | 0.5 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.0 | 0.3 | GO:1902713 | regulation of interferon-gamma secretion(GO:1902713) |
| 0.0 | 0.2 | GO:0036116 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.0 | 0.2 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
| 0.0 | 0.4 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
| 0.0 | 0.8 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.0 | 0.4 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
| 0.0 | 1.8 | GO:0061718 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.0 | 0.3 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.0 | 0.5 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.0 | 1.3 | GO:0042730 | fibrinolysis(GO:0042730) |
| 0.0 | 0.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.0 | 0.4 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 0.0 | 0.2 | GO:1904588 | cellular response to glycoprotein(GO:1904588) response to thyrotropin-releasing hormone(GO:1905225) cellular response to thyrotropin-releasing hormone(GO:1905229) |
| 0.0 | 0.1 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
| 0.0 | 0.4 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.0 | 0.1 | GO:2001189 | negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001189) |
| 0.0 | 0.1 | GO:0015822 | mitochondrial ornithine transport(GO:0000066) ornithine transport(GO:0015822) |
| 0.0 | 0.4 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
| 0.0 | 0.2 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.0 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 | 0.2 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.0 | 0.2 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.0 | 0.1 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.0 | 0.2 | GO:1900827 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.0 | 0.1 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.0 | 0.2 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
| 0.0 | 1.0 | GO:0045332 | phospholipid translocation(GO:0045332) |
| 0.0 | 1.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.0 | 1.0 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
| 0.0 | 3.9 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 | 0.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.0 | 0.2 | GO:0032439 | endosome localization(GO:0032439) |
| 0.0 | 0.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.0 | 0.1 | GO:0018874 | benzoate metabolic process(GO:0018874) |
| 0.0 | 1.1 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.0 | 0.4 | GO:0042262 | DNA protection(GO:0042262) |
| 0.0 | 0.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.0 | 1.4 | GO:1901998 | toxin transport(GO:1901998) |
| 0.0 | 0.4 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.0 | 0.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 0.0 | 0.5 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
| 0.0 | 0.1 | GO:0051758 | homologous chromosome movement towards spindle pole involved in homologous chromosome segregation(GO:0051758) |
| 0.0 | 1.1 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.0 | 1.3 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
| 0.0 | 0.5 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.0 | 0.9 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
| 0.0 | 0.1 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.0 | 2.5 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.0 | 0.2 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.0 | 0.7 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.0 | 0.2 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
| 0.0 | 2.2 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 | 0.4 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.0 | 0.5 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.0 | 0.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.0 | 0.7 | GO:0045730 | respiratory burst(GO:0045730) |
| 0.0 | 0.2 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.0 | 0.2 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 0.0 | 0.5 | GO:0006882 | cellular zinc ion homeostasis(GO:0006882) |
| 0.0 | 0.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.0 | 0.2 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.0 | 0.1 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.0 | 0.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.0 | 0.2 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
| 0.0 | 2.6 | GO:0048644 | muscle organ morphogenesis(GO:0048644) |
| 0.0 | 0.1 | GO:0021784 | postganglionic parasympathetic fiber development(GO:0021784) |
| 0.0 | 0.3 | GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.0 | 0.1 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.0 | 0.8 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
| 0.0 | 0.1 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.0 | 0.3 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 0.0 | 0.1 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.0 | 0.1 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.0 | 0.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 | 0.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 0.0 | 0.9 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 0.0 | 0.3 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
| 0.0 | 0.1 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.0 | 0.5 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.0 | 0.4 | GO:0045109 | intermediate filament organization(GO:0045109) |
| 0.0 | 0.4 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
| 0.0 | 0.2 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.0 | 1.0 | GO:0035036 | sperm-egg recognition(GO:0035036) |
| 0.0 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.0 | 0.3 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 0.0 | 0.3 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
| 0.0 | 0.8 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
| 0.0 | 0.3 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.0 | 0.1 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.0 | 0.8 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 0.0 | 0.3 | GO:0090179 | regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) planar cell polarity pathway involved in neural tube closure(GO:0090179) |
| 0.0 | 2.7 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
| 0.0 | 0.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.0 | 0.3 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.0 | 0.3 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.0 | 4.5 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
| 0.0 | 0.9 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.0 | 0.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.0 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.0 | 0.7 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.0 | 0.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.0 | 0.4 | GO:0030220 | platelet formation(GO:0030220) |
| 0.0 | 0.1 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
| 0.0 | 0.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.0 | 0.1 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
| 0.0 | 1.4 | GO:0030818 | negative regulation of cAMP biosynthetic process(GO:0030818) |
| 0.0 | 0.3 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.0 | 0.7 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.0 | 0.2 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.0 | 0.8 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.0 | 0.1 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 0.0 | 0.4 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.0 | 0.3 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.0 | 0.1 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.0 | 1.4 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
| 0.0 | 0.4 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.0 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.0 | 2.9 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.0 | 0.5 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
| 0.0 | 0.1 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.0 | 0.6 | GO:0001881 | receptor recycling(GO:0001881) |
| 0.0 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.0 | 0.3 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.0 | 0.7 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
| 0.0 | 0.4 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.0 | 0.1 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) |
| 0.0 | 0.5 | GO:1902116 | negative regulation of organelle assembly(GO:1902116) |
| 0.0 | 0.5 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.0 | 0.7 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.0 | 0.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 0.0 | 0.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.0 | 1.7 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.0 | 0.4 | GO:0019731 | antibacterial humoral response(GO:0019731) |
| 0.0 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.0 | 0.4 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 | 0.2 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
| 0.0 | 0.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.0 | 0.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.0 | 0.2 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
| 0.0 | 0.2 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
| 0.0 | 0.4 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.0 | 0.2 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 0.0 | 1.0 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
| 0.0 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.0 | 0.3 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
| 0.0 | 0.0 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.0 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
| 0.0 | 0.5 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 | 0.8 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.0 | 0.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.0 | 0.2 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.0 | 0.0 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) positive regulation of monocyte extravasation(GO:2000439) |
| 0.0 | 0.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.0 | 0.1 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.0 | 0.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.0 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.0 | 0.0 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.0 | 0.2 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
| 0.0 | 0.0 | GO:1900111 | regulation of histone H3-K9 dimethylation(GO:1900109) positive regulation of histone H3-K9 dimethylation(GO:1900111) positive regulation of histone H3-K9 trimethylation(GO:1900114) |
| 0.0 | 0.2 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 0.0 | 0.2 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
| 0.0 | 0.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.0 | 0.2 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
| 0.0 | 0.2 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.0 | 0.3 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
| 0.0 | 0.4 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
| 0.0 | 0.1 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.0 | 0.1 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.0 | 0.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.0 | 0.4 | GO:2001259 | positive regulation of cation channel activity(GO:2001259) |
| 0.0 | 0.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.0 | 0.0 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
| 0.0 | 0.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.0 | 0.1 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.0 | 0.5 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.0 | 0.9 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
| 0.0 | 0.1 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.0 | 0.1 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
| 0.0 | 1.0 | GO:0046718 | viral entry into host cell(GO:0046718) |
| 0.0 | 0.0 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.0 | 0.0 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
| 0.0 | 0.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.3 | 6.8 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 1.8 | 14.4 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 1.7 | 5.0 | GO:0071159 | NF-kappaB complex(GO:0071159) |
| 1.6 | 4.8 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
| 1.0 | 3.1 | GO:0005607 | laminin-2 complex(GO:0005607) |
| 1.0 | 4.0 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.6 | 4.9 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.6 | 1.7 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.5 | 5.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.5 | 1.5 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.5 | 10.0 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
| 0.5 | 1.4 | GO:0044753 | amphisome(GO:0044753) |
| 0.4 | 3.8 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.4 | 3.3 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) cytoplasmic side of late endosome membrane(GO:0098560) |
| 0.4 | 0.4 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
| 0.4 | 4.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.3 | 0.9 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
| 0.3 | 2.7 | GO:0005638 | lamin filament(GO:0005638) |
| 0.3 | 1.2 | GO:0001652 | granular component(GO:0001652) |
| 0.3 | 3.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.3 | 1.7 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.3 | 1.4 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.3 | 22.2 | GO:0015030 | Cajal body(GO:0015030) |
| 0.2 | 2.4 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.2 | 1.0 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.2 | 1.9 | GO:0070187 | telosome(GO:0070187) |
| 0.2 | 1.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.2 | 2.0 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.2 | 1.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.2 | 1.9 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.2 | 2.0 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.2 | 0.9 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.2 | 1.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.2 | 0.5 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
| 0.2 | 6.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.2 | 0.9 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 0.2 | 0.9 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 0.2 | 2.0 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.2 | 1.9 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.2 | 0.8 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 0.2 | 3.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.2 | 1.1 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.2 | 1.6 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.2 | 0.6 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.2 | 0.5 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.2 | 0.9 | GO:0032010 | phagolysosome(GO:0032010) |
| 0.1 | 0.7 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.1 | 2.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.1 | 0.6 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 0.1 | 0.4 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.1 | 0.4 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
| 0.1 | 1.3 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
| 0.1 | 2.4 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.1 | 0.5 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.1 | 0.1 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 0.1 | 1.0 | GO:0001940 | male pronucleus(GO:0001940) |
| 0.1 | 0.4 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
| 0.1 | 1.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.1 | 0.8 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.1 | 0.3 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.1 | 1.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.1 | 0.1 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.1 | 0.3 | GO:0001534 | radial spoke(GO:0001534) |
| 0.1 | 1.9 | GO:0032059 | bleb(GO:0032059) |
| 0.1 | 1.5 | GO:0030478 | actin cap(GO:0030478) |
| 0.1 | 0.4 | GO:0030934 | anchoring collagen complex(GO:0030934) |
| 0.1 | 1.4 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.1 | 0.6 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.1 | 0.8 | GO:0033010 | paranodal junction(GO:0033010) |
| 0.1 | 2.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.1 | 2.6 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.1 | 0.7 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.1 | 0.9 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.1 | 6.6 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.1 | 1.5 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.1 | 1.7 | GO:0001741 | XY body(GO:0001741) |
| 0.1 | 0.5 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
| 0.1 | 0.2 | GO:0035841 | new growing cell tip(GO:0035841) |
| 0.1 | 0.2 | GO:1990032 | parallel fiber(GO:1990032) |
| 0.1 | 2.5 | GO:0030057 | desmosome(GO:0030057) |
| 0.1 | 0.3 | GO:0001674 | female germ cell nucleus(GO:0001674) |
| 0.1 | 0.6 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.1 | 1.6 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.1 | 0.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.1 | 0.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.1 | 0.7 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.1 | 0.5 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.1 | 0.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 0.1 | 1.0 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
| 0.1 | 0.6 | GO:0000125 | PCAF complex(GO:0000125) |
| 0.1 | 3.7 | GO:0002102 | podosome(GO:0002102) |
| 0.1 | 1.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.1 | 0.5 | GO:0071437 | invadopodium(GO:0071437) |
| 0.1 | 0.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.0 | 1.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.0 | 0.2 | GO:0045179 | apical cortex(GO:0045179) |
| 0.0 | 0.3 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
| 0.0 | 0.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.0 | 0.8 | GO:0090543 | Flemming body(GO:0090543) |
| 0.0 | 0.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.0 | 1.1 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.0 | 0.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.0 | 1.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.0 | 0.4 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.0 | 4.0 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.0 | 0.3 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.0 | 0.1 | GO:0033503 | HULC complex(GO:0033503) |
| 0.0 | 0.7 | GO:0043218 | compact myelin(GO:0043218) |
| 0.0 | 1.1 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
| 0.0 | 0.2 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.0 | 0.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.0 | 0.2 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.0 | 0.5 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.0 | 0.2 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.0 | 0.7 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.0 | 1.7 | GO:0008305 | integrin complex(GO:0008305) |
| 0.0 | 0.3 | GO:0070938 | contractile ring(GO:0070938) |
| 0.0 | 11.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.0 | 0.2 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.0 | 0.1 | GO:0060187 | cell pole(GO:0060187) |
| 0.0 | 0.3 | GO:0097413 | Lewy body(GO:0097413) |
| 0.0 | 0.5 | GO:0042599 | lamellar body(GO:0042599) |
| 0.0 | 0.2 | GO:0034715 | U7 snRNP(GO:0005683) pICln-Sm protein complex(GO:0034715) |
| 0.0 | 0.1 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 0.0 | 7.0 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.0 | 1.0 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.0 | 0.1 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.0 | 0.4 | GO:0043073 | germ cell nucleus(GO:0043073) |
| 0.0 | 1.1 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.0 | 2.0 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.0 | 0.2 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 0.0 | 0.2 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.0 | 0.3 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.0 | 2.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.0 | 0.9 | GO:0005921 | gap junction(GO:0005921) |
| 0.0 | 0.1 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.0 | 0.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
| 0.0 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.0 | 0.6 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.0 | 0.3 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
| 0.0 | 0.2 | GO:0044754 | autolysosome(GO:0044754) |
| 0.0 | 1.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.0 | 0.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
| 0.0 | 0.1 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.0 | 0.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.0 | 0.3 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.0 | 3.2 | GO:0043296 | apical junction complex(GO:0043296) |
| 0.0 | 0.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.0 | 0.2 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.0 | 0.7 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.0 | 0.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.0 | 0.8 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.0 | 6.3 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.0 | 0.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.0 | 1.9 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.0 | 1.0 | GO:0000786 | nucleosome(GO:0000786) |
| 0.0 | 5.1 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.0 | 2.3 | GO:0044309 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
| 0.0 | 5.8 | GO:0005769 | early endosome(GO:0005769) |
| 0.0 | 1.3 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.0 | 0.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.0 | 5.6 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.0 | 0.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.0 | 0.5 | GO:0032420 | stereocilium(GO:0032420) |
| 0.0 | 0.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.0 | 0.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.0 | 0.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.0 | 1.3 | GO:0070820 | tertiary granule(GO:0070820) |
| 0.0 | 0.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.0 | 0.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.0 | 0.0 | GO:0030891 | VCB complex(GO:0030891) |
| 0.0 | 0.1 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
| 0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
| 0.0 | 0.7 | GO:0005776 | autophagosome(GO:0005776) |
| 0.0 | 1.5 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.0 | 0.1 | GO:0097486 | multivesicular body lumen(GO:0097486) |
| 0.0 | 0.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.0 | 0.3 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.0 | 0.8 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.0 | 0.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.4 | 22.1 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 2.9 | 14.4 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
| 1.9 | 5.8 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 1.9 | 5.8 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
| 1.3 | 3.9 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 1.2 | 6.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 1.1 | 6.8 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 1.1 | 3.2 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
| 1.0 | 4.8 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 1.0 | 3.8 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
| 0.9 | 6.9 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.8 | 3.1 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 0.7 | 3.5 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.6 | 1.9 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.6 | 1.9 | GO:0050135 | NAD(P)+ nucleosidase activity(GO:0050135) |
| 0.6 | 1.9 | GO:0002113 | interleukin-33 binding(GO:0002113) |
| 0.6 | 4.3 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 0.6 | 5.0 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.6 | 1.7 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
| 0.5 | 3.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.5 | 1.5 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
| 0.5 | 1.0 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.5 | 1.4 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
| 0.4 | 3.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.4 | 2.6 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.4 | 2.1 | GO:0048030 | disaccharide binding(GO:0048030) |
| 0.4 | 1.6 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
| 0.4 | 4.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.4 | 2.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.4 | 4.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.4 | 1.5 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.4 | 6.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.4 | 1.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.4 | 1.8 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.3 | 11.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.3 | 1.4 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 0.3 | 7.2 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.3 | 9.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.3 | 0.9 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
| 0.3 | 0.8 | GO:0047726 | iron-cytochrome-c reductase activity(GO:0047726) |
| 0.3 | 2.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.3 | 0.8 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.3 | 1.6 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.3 | 1.6 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.3 | 1.8 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.3 | 1.3 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 0.2 | 1.0 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
| 0.2 | 0.9 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.2 | 2.1 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.2 | 2.5 | GO:0008430 | selenium binding(GO:0008430) |
| 0.2 | 2.5 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.2 | 1.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.2 | 0.7 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 0.2 | 1.1 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
| 0.2 | 0.9 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 0.2 | 1.3 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.2 | 1.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.2 | 3.8 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.2 | 2.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.2 | 1.0 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
| 0.2 | 0.9 | GO:0015639 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
| 0.2 | 2.8 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.2 | 0.9 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
| 0.2 | 0.7 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.2 | 0.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.2 | 1.6 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.2 | 0.7 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
| 0.2 | 21.9 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.2 | 7.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.2 | 6.1 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.2 | 0.5 | GO:0036317 | tyrosyl-RNA phosphodiesterase activity(GO:0036317) 5'-tyrosyl-DNA phosphodiesterase activity(GO:0070260) |
| 0.2 | 0.6 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.2 | 1.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.2 | 0.5 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
| 0.1 | 1.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.1 | 0.4 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.1 | 0.4 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.1 | 1.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.1 | 0.4 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
| 0.1 | 0.8 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.1 | 1.6 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.1 | 0.8 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 0.1 | 3.7 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.1 | 7.6 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.1 | 0.4 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.1 | 0.1 | GO:0032427 | GBD domain binding(GO:0032427) |
| 0.1 | 1.6 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.1 | 1.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.1 | 0.5 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.1 | 1.1 | GO:0043426 | MRF binding(GO:0043426) |
| 0.1 | 0.4 | GO:0015229 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 0.1 | 0.7 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.1 | 0.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.1 | 2.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.1 | 1.6 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.1 | 0.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
| 0.1 | 0.3 | GO:0031403 | pyridoxal kinase activity(GO:0008478) lithium ion binding(GO:0031403) |
| 0.1 | 0.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.1 | 3.2 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.1 | 1.4 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.1 | 0.3 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
| 0.1 | 0.5 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 0.1 | 0.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.1 | 1.9 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.1 | 0.4 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 0.1 | 0.6 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
| 0.1 | 0.3 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 0.1 | 0.4 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.1 | 1.0 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.1 | 0.3 | GO:0003955 | NAD(P)H dehydrogenase (quinone) activity(GO:0003955) |
| 0.1 | 0.7 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.1 | 0.3 | GO:0090541 | MIT domain binding(GO:0090541) |
| 0.1 | 0.3 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.1 | 0.5 | GO:0030614 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
| 0.1 | 0.6 | GO:0070513 | death domain binding(GO:0070513) |
| 0.1 | 0.4 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
| 0.1 | 2.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.1 | 0.9 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.1 | 0.2 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
| 0.1 | 0.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.1 | 1.6 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.1 | 0.3 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.1 | 0.7 | GO:0071253 | connexin binding(GO:0071253) |
| 0.1 | 1.2 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 1.5 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.1 | 1.1 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.1 | 0.6 | GO:0050815 | phosphoserine binding(GO:0050815) phosphothreonine binding(GO:0050816) |
| 0.1 | 0.5 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.1 | 0.3 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.1 | 0.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.1 | 2.0 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.1 | 2.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
| 0.1 | 0.1 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
| 0.1 | 0.4 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.1 | 0.4 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.1 | 2.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.1 | 0.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.1 | 1.1 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.1 | 0.8 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.1 | 3.3 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.1 | 0.8 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.1 | 1.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.1 | 1.5 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
| 0.1 | 0.2 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
| 0.1 | 0.2 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
| 0.1 | 1.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.1 | 1.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.1 | 1.1 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.1 | 0.2 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.1 | 1.7 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.1 | 0.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
| 0.1 | 1.7 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
| 0.1 | 1.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.1 | 0.7 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.1 | 0.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.1 | 1.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
| 0.1 | 0.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.1 | 0.5 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 0.0 | 0.4 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.0 | 0.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 0.0 | 0.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.0 | 0.2 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.0 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.0 | 0.7 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 0.0 | 1.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.0 | 1.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.0 | 0.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.0 | 0.2 | GO:0061714 | folic acid receptor activity(GO:0061714) |
| 0.0 | 0.2 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
| 0.0 | 0.2 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.0 | 1.5 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 0.0 | 0.7 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
| 0.0 | 0.7 | GO:0051393 | alpha-actinin binding(GO:0051393) |
| 0.0 | 0.2 | GO:0051800 | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity(GO:0051800) |
| 0.0 | 0.4 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.0 | 1.7 | GO:0001848 | complement binding(GO:0001848) |
| 0.0 | 0.9 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.0 | 0.6 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.0 | 1.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.0 | 0.7 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
| 0.0 | 6.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.0 | 0.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.0 | 0.2 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.0 | 0.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.0 | 0.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.0 | 0.3 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
| 0.0 | 0.7 | GO:0001163 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.0 | 0.3 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.0 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.0 | 1.0 | GO:0005112 | Notch binding(GO:0005112) |
| 0.0 | 0.2 | GO:0017161 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 0.0 | 0.4 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.0 | 0.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.0 | 0.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.0 | 0.4 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.0 | 0.5 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
| 0.0 | 1.5 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.0 | 3.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.0 | 0.2 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 0.0 | 1.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.0 | 0.1 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.0 | 4.9 | GO:0008144 | drug binding(GO:0008144) |
| 0.0 | 0.3 | GO:0008865 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.0 | 0.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.0 | 1.9 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.0 | 0.1 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
| 0.0 | 0.2 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.0 | 1.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.0 | 0.4 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.0 | 0.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.0 | 1.8 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.0 | 0.2 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.0 | 1.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.0 | 0.6 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.0 | 0.3 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
| 0.0 | 0.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.0 | 0.9 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.0 | 0.1 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
| 0.0 | 0.2 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 0.0 | 0.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.0 | 0.1 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
| 0.0 | 0.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.0 | 0.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.0 | 0.1 | GO:0033149 | FFAT motif binding(GO:0033149) |
| 0.0 | 0.7 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.0 | 1.1 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.0 | 1.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.0 | 0.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 0.0 | 0.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.0 | 0.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.0 | 0.4 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.0 | 0.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.0 | 0.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.0 | 0.4 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.0 | 0.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.0 | 1.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.0 | 0.1 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
| 0.0 | 0.3 | GO:0016004 | phospholipase activator activity(GO:0016004) |
| 0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
| 0.0 | 0.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.0 | 4.0 | GO:0008201 | heparin binding(GO:0008201) |
| 0.0 | 0.1 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) sodium:proton antiporter activity(GO:0015385) |
| 0.0 | 0.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.0 | 0.1 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.0 | 0.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.0 | 0.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.0 | 0.9 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.0 | 0.2 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) G-rich strand telomeric DNA binding(GO:0098505) |
| 0.0 | 0.6 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.0 | 0.4 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.0 | 0.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.0 | 0.5 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
| 0.0 | 0.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
| 0.0 | 0.1 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
| 0.0 | 0.1 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.0 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
| 0.0 | 0.5 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.0 | 0.1 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.0 | 0.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.0 | 2.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.0 | 12.0 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
| 0.0 | 0.4 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
| 0.0 | 0.6 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 0.0 | 1.1 | GO:0002039 | p53 binding(GO:0002039) |
| 0.0 | 1.4 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.0 | 0.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.0 | 0.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.0 | 0.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.0 | 1.8 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) |
| 0.0 | 0.1 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 0.0 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
| 0.0 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.0 | 0.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.0 | 0.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.0 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.0 | 0.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.0 | 0.2 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.0 | 0.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.0 | 1.0 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
| 0.0 | 0.0 | GO:0004040 | amidase activity(GO:0004040) |
| 0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
| 0.0 | 3.0 | GO:0000287 | magnesium ion binding(GO:0000287) |
| 0.0 | 0.4 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.0 | 0.3 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
| 0.0 | 0.4 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.0 | 0.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.0 | 0.8 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.0 | 0.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.0 | 1.1 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.0 | 0.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.0 | 0.2 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.0 | 0.0 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.0 | 0.0 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 0.0 | 0.0 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
| 0.0 | 0.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.0 | 0.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.0 | 0.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 3.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.4 | 12.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.4 | 22.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.4 | 13.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.4 | 8.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.3 | 12.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.2 | 13.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.2 | 4.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.2 | 9.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.1 | 6.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.1 | 1.8 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 0.1 | 0.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.1 | 4.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.1 | 7.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.1 | 2.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.1 | 2.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.1 | 1.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.1 | 2.9 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.1 | 0.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.1 | 0.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.1 | 1.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.1 | 2.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.1 | 6.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.1 | 0.5 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.1 | 1.0 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
| 0.1 | 2.7 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.1 | 8.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.1 | 5.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.1 | 0.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.1 | 3.4 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.1 | 5.0 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.1 | 1.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.1 | 0.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.1 | 3.4 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.1 | 0.8 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.1 | 1.3 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.1 | 1.1 | ST GAQ PATHWAY | G alpha q Pathway |
| 0.1 | 0.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.1 | 3.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.1 | 0.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.0 | 1.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.0 | 1.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.0 | 2.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.0 | 2.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.0 | 0.6 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.0 | 0.7 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.0 | 0.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.0 | 1.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.0 | 2.8 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.0 | 1.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.0 | 1.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.0 | 1.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.0 | 13.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.0 | 1.7 | PID ATR PATHWAY | ATR signaling pathway |
| 0.0 | 0.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.0 | 2.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.0 | 0.6 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.0 | 0.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.0 | 0.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.0 | 0.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.0 | 1.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.0 | 0.7 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.0 | 0.7 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.0 | 0.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 0.0 | 0.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.0 | 0.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.0 | 0.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.0 | 0.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.0 | 0.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.0 | 0.5 | PID MYC PATHWAY | C-MYC pathway |
| 0.0 | 0.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
| 0.0 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.0 | 0.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.0 | 0.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.0 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.0 | 0.8 | PID P73PATHWAY | p73 transcription factor network |
| 0.0 | 0.7 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.0 | 0.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.0 | 0.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.0 | 0.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.0 | 0.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.0 | 0.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.0 | 0.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.0 | 0.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 0.5 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 0.5 | 14.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.4 | 2.7 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.4 | 40.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.4 | 6.8 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 0.4 | 10.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.4 | 7.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.3 | 6.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.3 | 2.5 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.3 | 19.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.3 | 9.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.3 | 19.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.3 | 11.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.2 | 9.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.2 | 4.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.2 | 6.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.2 | 4.8 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.2 | 4.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.2 | 5.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.2 | 3.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.1 | 0.7 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
| 0.1 | 2.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.1 | 2.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.1 | 6.1 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.1 | 1.3 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.1 | 1.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.1 | 1.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.1 | 2.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.1 | 1.8 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 0.1 | 1.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.1 | 3.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.1 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.1 | 1.5 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.1 | 2.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.1 | 0.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.1 | 1.5 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
| 0.1 | 0.8 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
| 0.1 | 1.7 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.1 | 6.0 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.1 | 1.0 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.1 | 1.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.1 | 3.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.1 | 1.0 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.1 | 4.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.1 | 2.7 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
| 0.1 | 2.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.1 | 1.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.1 | 2.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 0.1 | 1.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.1 | 1.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.0 | 1.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.0 | 1.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.0 | 6.3 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
| 0.0 | 0.8 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.0 | 1.1 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 0.0 | 0.7 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.0 | 2.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.0 | 1.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.0 | 0.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.0 | 4.9 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.0 | 2.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.0 | 0.9 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
| 0.0 | 0.9 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.0 | 0.5 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.0 | 0.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.0 | 2.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.0 | 5.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.0 | 0.5 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.0 | 0.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.0 | 1.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.0 | 0.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.0 | 0.9 | REACTOME DEFENSINS | Genes involved in Defensins |
| 0.0 | 0.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.0 | 1.3 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.0 | 2.0 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.0 | 2.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.0 | 0.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.0 | 0.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.0 | 0.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.0 | 0.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.0 | 1.2 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.0 | 1.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.0 | 0.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.0 | 0.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.0 | 2.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.0 | 0.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.0 | 0.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.0 | 0.4 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.0 | 0.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.0 | 0.4 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
| 0.0 | 1.0 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.0 | 0.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.0 | 0.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.0 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.0 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.0 | 0.9 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
| 0.0 | 0.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.0 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.0 | 0.1 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |